Search results
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 4 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
First National Bank Sioux Falls Has $822,000 Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 20 hours agoFirst National Bank Sioux Falls lifted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.0% during the fourth quarter, according to the company in its most recent Form ...
Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey
ETF DAILY NEWS· 5 days agoBristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...
More people exposed to Manhattan Project chemicals deserve compensation, advocates say
Fox News· 5 days agoThe Radiation Exposure Compensation Act has been a lifeline for some people and families exposed to...
AbbVie (ABBV) to Release Quarterly Earnings on Friday
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) is scheduled to be issuing its quarterly earnings data before the market opens on Friday, April 26th. Analysts expect the company to announce earnings of ...
Rush In The Studio For 'Grace Under Pressure' 40th Anniversary
antiMUSIC· 16 hours agoThe 40th anniversary of Rush's "Grace Under Pressure" album is being celebrated with a Medium Rare episode by the syndicated radio show In The Studio With Redbeard: The Stories Behind History's ...
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...
Morningstar· 4 days agoFaruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and reminds investors ...
Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...
Benzinga· 6 days agoThe confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid
Johnson & Johnson (NYSE:JNJ) is Illinois Municipal Retirement Fund’s 10th Largest Position
ETF DAILY NEWS· 1 day agoIllinois Municipal Retirement Fund raised its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 4.4% in the fourth quarter, according to the company in its most recent disclosure ...
Rakuten Securities Inc. Makes New Investment in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 7 days agoRakuten Securities Inc. bought a new stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...